# Pentoxifylline Dose Optimization in Neonatal Sepsis

> **NCT04152980** · PHASE3 · COMPLETED · sponsor: **Erasmus Medical Center** · enrollment: 30 (actual)

## Conditions studied

- Neonatal Late Onset Sepsis

## Interventions

- **DRUG:** Pentoxifylline

## Key facts

- **NCT ID:** NCT04152980
- **Lead sponsor:** Erasmus Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-01-12
- **Primary completion:** 2022-10-31
- **Final completion:** 2022-12-31
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2024-08-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04152980

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04152980, "Pentoxifylline Dose Optimization in Neonatal Sepsis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04152980. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*